Clinical Trials

192 enrolled 22 charts

Hematologic Neoplasms

NCT04307134 2025-12-31

Besponsa Post Marketing Surveillance Study

LymphoidOther hematologic neoplasm

108 enrolled 39 charts

Burkitt Lymphoma, Hematologic Neoplasms

NCT02680795 2025-10-20

Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes

17 enrolled

Hematologic Neoplasms

NCT05391022 2025-07-28

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

35 enrolled

Hematologic Neoplasms

NCT05549232 2025-07-23

Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

22 enrolled 18 charts

Hypoxia, Burns, Hematologic Neoplasms

NCT05599932 2025-07-09

Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment

38 enrolled

Hematologic Neoplasms

NCT04260698 2025-07-02

Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

Phase 3 Completed

36 enrolled

Hematologic Neoplasms

NCT02329847 2025-05-25

A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies

144 enrolled 22 charts

Hematologic Neoplasms

NCT02494258 2025-05-22

A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

5 enrolled

Hematologic Diseases, Neoplasms, Hematologic Neoplasms

NCT04283097 2025-05-16

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

30 enrolled

Hematologic Neoplasms

NCT04886622 2025-04-16

A Study of DT2216 in Relapsed/Refractory Malignancies

20 enrolled

Hematologic Neoplasms

NCT04889937 2025-03-11

PC004

46 enrolled

Hematologic Neoplasms

NCT01420770 2025-03-05

Phase 2 Study of SAR302503 in Patients With Myelofibrosis

30 enrolled

Hematologic Neoplasms

NCT01420783 2025-03-05

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

81 enrolled

Hematologic Neoplasms

NCT01437787 2025-03-05

JAKARTA

Phase 3 Completed

289 enrolled 1 FDA

Hematologic Neoplasms

NCT01523171 2025-03-05

JAKARTA2

97 enrolled

Hematologic Neoplasms

NCT02636855 2025-03-04

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

9,122 enrolled

Neoplasm Metastasis, Neoplasms, Hematologic Neoplasms

NCT02038777 2025-02-26

A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies

48 enrolled 85 charts

Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT00788684 2025-02-20

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

LymphoidOther hematologic neoplasm

29 enrolled

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Hematologic Neoplasms

NCT04537715 2025-02-19

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

LymphoidOther hematologic neoplasmOther solid neoplasmSarcomaThoracic

42 enrolled 39 charts

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

NCT05819762 2024-12-04

Evaluation of ClearLLab LS Screening Panel

831 enrolled

Hematologic Diseases, Hematologic Neoplasms

NCT03241550 2024-11-19

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

49 enrolled

Invasive Fungal Infections, Hematologic Neoplasms

NCT01915498 2024-10-22

Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation

345 enrolled 120 charts 1 FDA

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT06586671 2024-09-19

MK-1026-007

40 enrolled

Hematologic Neoplasms

NCT04649112 2024-07-26

Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies

13 enrolled

Hematologic Neoplasms

NCT02576496 2024-07-25

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

DermatologicLymphoidOther hematologic neoplasmPlasma cell

106 enrolled

Hodgkin Disease, Multiple Myeloma, Lymphoma, T-Cell, Cutaneous, Hematologic Neoplasms

NCT01611142 2024-06-17

Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)

LymphoidOther hematologic neoplasm

38 enrolled

Neoplasms, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms

NCT05064787 2024-05-24

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Phase NA Completed

45 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03711604 2024-05-08

Compassionate Use Study of Tenalisib (RP6530)

17 enrolled 9 charts

Hematologic Neoplasms

NCT00953758 2024-04-25

A Study Of PF-04449913 In Select Hematologic Malignancies

47 enrolled 45 charts

Hematologic Neoplasms

NCT05467449 2024-02-13

DxFLEX 10C Clinical Study

527 enrolled

Hematologic Neoplasms

NCT02352558 2023-11-14

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasmPlasma cell

15 enrolled

Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT01063647 2023-11-03

Dose-range Finding Treosulfan-based Conditioning

56 enrolled

Hematologic Neoplasms

NCT02711852 2023-09-11

A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

19 enrolled 11 charts

Hematologic Neoplasms

NCT04257617 2023-08-22

A Trial of ZL-1201 in Subjects With Advanced Cancer

37 enrolled

Hematologic Neoplasms

NCT04184869 2023-05-03

Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

8 enrolled

Hematologic Neoplasms

NCT02743351 2023-02-08

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasm

96 enrolled 13 charts

Bronchiolitis Obliterans Syndrome, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03386526 2023-02-01

APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

90 enrolled

Hematologic Neoplasms

NCT01607892 2023-01-26

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

286 enrolled 26 charts

Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03082209 2022-12-09

A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies

GastrointestinalLymphoidOther hematologic neoplasm

153 enrolled

Lymphoma, Non-Hodgkin, Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Phase 3 Completed

1,718 enrolled 22 charts

Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT04264767 2022-06-08

Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

800 enrolled

Neoplasms, Hematologic Neoplasms

NCT04944771 2022-05-09

Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants

48 enrolled

Hematologic Neoplasms

NCT03787498 2022-04-12

A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

MyeloidOther hematologic neoplasm

22 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02367196 2021-08-12

A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers

60 enrolled

Hematologic Neoplasms

NCT01221857 2021-08-03

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies